Latest International Markets News

Artrya Limited has successfully completed a strongly supported Share Purchase Plan, raising approximately A$5 million despite significant oversubscription. This follows a recent $75 million placement, underscoring investor confidence in its AI-driven coronary artery disease platform.

The Calmer Co International Limited has reported its strongest quarterly revenue ever at $2.4 million, driven by robust Australian retail sales and expanding US market presence. The company is also advancing a $1.4 million convertible note to fuel growth and inventory expansion.

Orthocell has reported a record $3 million revenue for the September quarter, driven by strong sales of its nerve repair product Remplir™ in Australia and Singapore, with early US sales and Canadian market entry poised to accelerate growth.

Broken Hill Mines has locked in a US$25 million senior secured financing facility alongside a major silver-lead concentrate offtake agreement with Hartree Metals, underpinning growth at its Rasp and Pinnacles mines.

Gowing Bros. Limited posted a $3.29 million loss for FY25 but declared a fully franked 3 cent final dividend, highlighting ongoing development at Sawtell Commons and a strong sustainability agenda.

Firebird Metals has raised A$6 million through a placement led by top-tier institutions and directors, aiming to fast-track its manganese-rich cathode technology and expand R&D capabilities in Australia and China.

The Calmer Co. has secured $700,000 in the first tranche of a $1.4 million convertible note raise, welcoming US distributor Applied Food Sciences as a strategic investor to fuel its expanding wholesale presence.

Murray Cod Australia has raised approximately A$17 million through an institutional placement to fund a significant expansion in production capacity and sales capabilities as it enters a pivotal growth phase.

KMD Brands reported a modest 1% sales increase in FY25 but faced a sharp 65% drop in underlying EBITDA, prompting a bold 'Next Level' turnaround strategy targeting margin expansion and debt reduction in FY26.

Decidr AI Industries has successfully completed a $20 million placement, positioning itself to accelerate international growth and advance its AI technology platform.

Imricor Medical Systems has successfully completed a comprehensive Human Factors study for all its devices under FDA review, marking a critical milestone towards U.S. market entry. The extensive 7-month study involved 46 healthcare professionals and tested nine products, underscoring Imricor’s growing momentum in electrophysiology innovation.

Epsilon Healthcare’s manufacturing arm has secured updated GMP certificates covering domestic and EU/UK markets, reinforcing its quality credentials and paving the way for expanded international contract manufacturing.